BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Saved in:
| Title: | BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. |
|---|---|
| Authors: | Coussy F; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., El-Botty R; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Château-Joubert S; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France., Dahmani A; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Montaudon E; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Leboucher S; Institut Curie, PSL Research University, UMR3306, 91405 Orsay, France., Morisset L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Painsec P; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Sourd L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Huguet L; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Nemati F; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Servely JL; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.; INRA, PHASE Department, 37380 Nouzilly, France., Larcher T; INRA, APEX-PAnTher, Oniris, 44300 Nantes, France., Vacher S; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Briaux A; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Reyes C; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., La Rosa P; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France., Lucotte G; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France., Popova T; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France., Foidart P; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Sounni NE; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Noel A; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium., Decaudin D; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France., Fuhrmann L; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France., Salomon A; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France., Reyal F; Surgery Department, Institut Curie, PSL Research University, 75005 Paris, France.; U932, Immunity and Cancer, INSERM, Institut Curie, 75005 Paris, France., Mueller C; Queen's Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada., Ter Brugge P; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands., Jonkers J; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands., Poupon MF; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France., Stern MH; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France., Bièche I; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. elisabetta.marangoni@curie.fr pommier@nih.gov., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France. elisabetta.marangoni@curie.fr pommier@nih.gov. |
| Source: | Science translational medicine [Sci Transl Med] 2020 Feb 19; Vol. 12 (531). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32075943 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Coussy+F%22">Coussy F</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22El-Botty+R%22">El-Botty R</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Château-Joubert+S%22">Château-Joubert S</searchLink>; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.<br /><searchLink fieldCode="AU" term="%22Dahmani+A%22">Dahmani A</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Montaudon+E%22">Montaudon E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Leboucher+S%22">Leboucher S</searchLink>; Institut Curie, PSL Research University, UMR3306, 91405 Orsay, France.<br /><searchLink fieldCode="AU" term="%22Morisset+L%22">Morisset L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Painsec+P%22">Painsec P</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Sourd+L%22">Sourd L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Huguet+L%22">Huguet L</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Nemati+F%22">Nemati F</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Servely+JL%22">Servely JL</searchLink>; BioPôle Alfort, Ecole Nationale Vétérinaire d'Alfort, 94704 Maisons Alfort, France.; INRA, PHASE Department, 37380 Nouzilly, France.<br /><searchLink fieldCode="AU" term="%22Larcher+T%22">Larcher T</searchLink>; INRA, APEX-PAnTher, Oniris, 44300 Nantes, France.<br /><searchLink fieldCode="AU" term="%22Vacher+S%22">Vacher S</searchLink>; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Briaux+A%22">Briaux A</searchLink>; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyes+C%22">Reyes C</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22La+Rosa+P%22">La Rosa P</searchLink>; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Lucotte+G%22">Lucotte G</searchLink>; INSERM, U900, 75005 Paris, France.; Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Popova+T%22">Popova T</searchLink>; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Foidart+P%22">Foidart P</searchLink>; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.<br /><searchLink fieldCode="AU" term="%22Sounni+NE%22">Sounni NE</searchLink>; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.<br /><searchLink fieldCode="AU" term="%22Noel+A%22">Noel A</searchLink>; Laboratory of Tumor and Developmental Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer (GIGA-Cancer), University of Liège, Liège 4000, Belgium.<br /><searchLink fieldCode="AU" term="%22Decaudin+D%22">Decaudin D</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.; Medical Oncology Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Fuhrmann+L%22">Fuhrmann L</searchLink>; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Salomon+A%22">Salomon A</searchLink>; Department of Pathology, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Surgery Department, Institut Curie, PSL Research University, 75005 Paris, France.; U932, Immunity and Cancer, INSERM, Institut Curie, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Mueller+C%22">Mueller C</searchLink>; Queen's Cancer Research Institute, Queen's University, Kingston, ON K7L 3N6, Canada.<br /><searchLink fieldCode="AU" term="%22Ter+Brugge+P%22">Ter Brugge P</searchLink>; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands.<br /><searchLink fieldCode="AU" term="%22Jonkers+J%22">Jonkers J</searchLink>; Division of Molecular Pathology and Cancer Genomics Centre Netherlands, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands.<br /><searchLink fieldCode="AU" term="%22Poupon+MF%22">Poupon MF</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Stern+MH%22">Stern MH</searchLink>; Institut Curie, PSL Research University, 75005 Paris, France.; INSERM U830, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Bièche+I%22">Bièche I</searchLink>; Genetics Department, Institut Curie, PSL Research University, 75005 Paris, France.<br /><searchLink fieldCode="AU" term="%22Pommier+Y%22">Pommier Y</searchLink>; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. elisabetta.marangoni@curie.fr pommier@nih.gov.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Translational Research Department, Institut Curie, PSL Research University, 75005 Paris, France. elisabetta.marangoni@curie.fr pommier@nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2020 Feb 19; Vol. 12 (531). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32075943 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/scitranslmed.aax2625 Languages: – Code: eng Text: English Titles: – TitleFull: BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Coussy F – PersonEntity: Name: NameFull: El-Botty R – PersonEntity: Name: NameFull: Château-Joubert S – PersonEntity: Name: NameFull: Dahmani A – PersonEntity: Name: NameFull: Montaudon E – PersonEntity: Name: NameFull: Leboucher S – PersonEntity: Name: NameFull: Morisset L – PersonEntity: Name: NameFull: Painsec P – PersonEntity: Name: NameFull: Sourd L – PersonEntity: Name: NameFull: Huguet L – PersonEntity: Name: NameFull: Nemati F – PersonEntity: Name: NameFull: Servely JL – PersonEntity: Name: NameFull: Larcher T – PersonEntity: Name: NameFull: Vacher S – PersonEntity: Name: NameFull: Briaux A – PersonEntity: Name: NameFull: Reyes C – PersonEntity: Name: NameFull: La Rosa P – PersonEntity: Name: NameFull: Lucotte G – PersonEntity: Name: NameFull: Popova T – PersonEntity: Name: NameFull: Foidart P – PersonEntity: Name: NameFull: Sounni NE – PersonEntity: Name: NameFull: Noel A – PersonEntity: Name: NameFull: Decaudin D – PersonEntity: Name: NameFull: Fuhrmann L – PersonEntity: Name: NameFull: Salomon A – PersonEntity: Name: NameFull: Reyal F – PersonEntity: Name: NameFull: Mueller C – PersonEntity: Name: NameFull: Ter Brugge P – PersonEntity: Name: NameFull: Jonkers J – PersonEntity: Name: NameFull: Poupon MF – PersonEntity: Name: NameFull: Stern MH – PersonEntity: Name: NameFull: Bièche I – PersonEntity: Name: NameFull: Pommier Y – PersonEntity: Name: NameFull: Marangoni E IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 02 Text: 2020 Feb 19 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1946-6242 Numbering: – Type: volume Value: 12 – Type: issue Value: 531 Titles: – TitleFull: Science translational medicine Type: main |
| ResultId | 1 |